Company
Every investor coverage indicates participated in a round BCAL raised.
Companies BCAL acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming BCAL. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Street Talk reports BCAL Diagnostics' takeover plan for Genetic Signatures collapsed once the target's talks with Sonic-backed Microba surfaced, with a three-company combination now under discussion.
Cut Through Venture's debut quarterly newsletter rounds up Q1 2021 raises across Australian and New Zealand startups, highlighting crowdfunding, fintech dominance, active investors, and two newly launched startups currently seeking backers.